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Cannabinoid receptor subtype 2 
(CB2R) agonist, GW405833 reduces 
agonist-induced Ca2+ oscillations in 
mouse pancreatic acinar cells
Zebing Huang1,2, Haiyan Wang3, Jingke Wang3,†, Mengqin Zhao3, Nana Sun3, Fangfang Sun3, 
Jianxin Shen3, Haiying Zhang4, Kunkun Xia2,‡, Dejie Chen2,§, Ming Gao2, Ronald P. Hammer5,6, 
Qingrong Liu4, Zhengxiong Xi4, Xuegong Fan1,* & Jie Wu1,2,3,5,*
Emerging evidence demonstrates that the blockade of intracellular Ca2+ signals may protect pancreatic 
acinar cells against Ca2+ overload, intracellular protease activation, and necrosis. The activation of 
cannabinoid receptor subtype 2 (CB2R) prevents acinar cell pathogenesis in animal models of acute 
pancreatitis. However, whether CB2Rs modulate intracellular Ca2+ signals in pancreatic acinar cells 
is largely unknown. We evaluated the roles of CB2R agonist, GW405833 (GW) in agonist-induced 
Ca2+ oscillations in pancreatic acinar cells using multiple experimental approaches with acute 
dissociated pancreatic acinar cells prepared from wild type, CB1R-knockout (KO), and CB2R-KO mice. 
Immunohistochemical labeling revealed that CB2R protein was expressed in mouse pancreatic acinar 
cells. Electrophysiological experiments showed that activation of CB2Rs by GW reduced acetylcholine 
(ACh)-, but not cholecystokinin (CCK)-induced Ca2+ oscillations in a concentration-dependent manner; 
this inhibition was prevented by a selective CB2R antagonist, AM630, or was absent in CB2R-KO but 
not CB1R-KO mice. In addition, GW eliminated L-arginine-induced enhancement of Ca2+ oscillations, 
pancreatic amylase, and pulmonary myeloperoxidase. Collectively, we provide novel evidence that 
activation of CB2Rs eliminates ACh-induced Ca2+ oscillations and L-arginine-induced enhancement of 
Ca2+ signaling in mouse pancreatic acinar cells, which suggests a potential cellular mechanism of CB2R-
mediated protection in acute pancreatitis.
Acute pancreatitis is an inflammatory disease, which has several causes and symptoms and requires immediate 
medical attention1,2. In clinical practice, there are still no efficient drugs that specifically treat acute pancreatitis1. 
Emerging evidence demonstrates that a primary event initiating the process of acute pancreatitis is the excessive 
release of Ca2+ from intracellular stores3. These studies provide a promising therapeutic strategy—the blockade 
of Ca2+ release-activated Ca2+ currents in pancreatic acinar cells may provide significant protection against Ca2+ 
overload, intracellular protease activation, and necrosis, which are the major triggers of acute pancreatitis.
The cannabinoid receptor type 2 (CB2R) is a G protein-coupled receptor that, in humans, is encoded by the 
CNR2 gene4. CB2Rs are predominantly expressed in the periphery, especially in immune cells, suggesting that 
CB2R mediates the effects of cannabinoids mainly in the immune system. For example, activation of CB2Rs 
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inhibits adenylyl cyclase via Gi/Goα subunits and causes a reduction in the intracellular level of cyclic adenosine 
monophosphate (cAMP)5,6, which has been implicated in a variety of modulatory functions including immune 
suppression, induction of apoptosis, and induction of cell migration7. Thus, CB2R agonists may be useful can-
didates for treating inflammatory diseases and pain8. Consistent with these findings, increased CB2R expression 
has been observed in spinal cord, dorsal root ganglion, and activated microglia in a rodent model of neuropathic 
pain, as well as in human hepatocellular carcinoma tumor samples9. In addition, emerging data demonstrate that 
CB2R mRNA and protein are expressed in pancreatic acinar cells, and activation of these CB2Rs prevents acinar 
cell pathogenesis in an animal model of pancreatitis10. However, whether the activation of CB2R modulates intra-
cellular Ca2+ signals in pancreatic acinar cells is largely unknown. Specifically, it is unknown whether an agent 
that induces pancreatitis (e.g., L-arginine) enhances Ca2+ oscillations and whether application of a CB2R agonist 
eliminates L-arginine-induced enhancement of Ca2+ oscillations in pancreatic acinar cells.
In this study, we address these important questions using patch-clamp and confocal Ca2+ imaging approaches 
combined with immunohistochemistry using wild-type (WT), CB1R-knockout (KO), and CB2R-KO mice.
Methods
All experimental protocols were approved by and performed in accordance with guidelines set by the animal 
care and use and ethical committees at the Barrow Neurological Institute, Xiangya Hospital (Hunan, Changsha, 
China), and Shantou University Medical College (Shantou, Guangdong, China).
Animals. Mice used for this study were adult (4–6 month old), male, CD1 mice (Charles River Laboratories 
International, Inc., Wilmington, MA, USA). In addition, WT, CB1RKO11, and CB2RKO mice12 with C57BL/6J 
genetic backgrounds were initially provided by Dr. Zheng-Xiong Xi at the National Institute on Drug Abuse 
(NIDA; Bethesda, MD, USA), and were then bred in animal facilities at the Barrow Neurological Institute, which 
are accredited by the Association for Assessment and Accreditation of Laboratory Animal Care. Genotyping was 
performed at the NIDA Intramural Research Program before experiments were begun. All animals used in the 
experiments were matched for age (8–14 weeks) and weight (25–35 grams).
Mouse Pancreatic Acinar Cell Preparation. Acute isolated pancreatic cells were prepared as previously 
described13–15. In brief, pancreatic glands were taken from isoflurane-anesthetized mice, and fragments of the 
tissue were minced and digested using collagenase (200 U/mL, 25–30 min, 37 °C; Wako Pure Chemicals, Osaka, 
Japan) in the presence of 1-mM Ca2+. After collagenase digestion, the cell suspension was gently pipetted to 
obtain further separation of the cells, and then washed with physiological saline. A 100-μ L volume of cell suspen-
sion was then poured into extracellular solution in a 2-mL experimental bath. The isolated cells usually adhered 
to the bottom within 15–20 min and were used for recording within 3 h after preparation. All experiments were 
performed at room temperature (22 ± 1 °C).
Whole-Cell Patch-Clamp Recording and Perforated-Patch Recording. Conventional whole-cell 
patch-clamp recording was used to record the Ca2+-activated Cl− currents for monitoring intracellular Ca2+ 
signal oscillations, as reported previously13,14. The recording pipettes, made from borosilicate glass capillaries, 
had a resistance of 3–5 MΩ when filled with pipette solution. After a GΩ seal was established between the cell 
membrane and the pipette, a whole-cell configuration was achieved by brief negative suction. Transmembrane 
currents were recorded with a patch-clamp amplifier (Axopatch 200B; Molecular Devices, Sunnyvale, CA, USA) 
at a holding potential (VH) of − 30 mV. For perforated-patch recording, amphotericin B (200 μ g/mL) was dis-
solved into the pipette solution. In these studies, we did not compensate for series resistance.
Drug Application. A stream of standard extracellular solution was continuously perfused over the cell dur-
ing recording. A computer-controlled U-tube system was used for drug application16. For intracellular drug appli-
cation, the drug was added into pipette solution, and establishment of a whole-cell configuration allowed the drug 
to diffuse into the recorded cell.
Amylase Estimation. Serum amylase activity was measured using the AMS assay kit (Nanjing Jiancheng 
Corp., Nanjing, China) and a microplate reader, following the manufacturer’s recommendations.
Myeloperoxidase Estimation. To measure myeloperoxidase (MPO) activity, lung tissues were imme-
diately homogenized on ice in 10 volumes of normal saline. MPO activity was measured using the MPO 
assay kit (Nanjing Jiancheng Corp., Nanjing, China) and a microplate reader, following the manufacturer’s 
recommendations.
CB2R Immunoblot Assay. WT, CB1R-KO, and CB2R- KO mice (3 mice for each group) were anesthetized 
and quickly perfused with saline to flash all blood cells. Both whole striatum and spleen tissue were dissected out, 
snap frozen, and kept on dry ice. All the tissues were homogenized in cell lysis buffer (Cell Signaling Technology, 
Inc., Danvers, MA, USA) using a sonicator and centrifuge at 15,000 rpm for 15 min at 4 °C to get supernatant. 
The protein concentration for each sample was quantified with a Bio-Rad Protein Assay (Bio-Rad Laboratories, 
Hercules, CA, USA). A total of 20-μ g protein (spleen) or 40-μ g protein (striatum) were loaded and separated by 
SDS-PAGE in a 4–15% gradient gel for the detection of endogenous calnexin (Enzo Life Sciences, SPA865) and 
CB2R (NIDA-5633) by using Invitrogen blotting and transferring modules (Grand Island, NY, USA). Membranes 
were blocked for 2 h at room temperature with Licor Odyssey blocking buffer (LI-COR Biosciences, Lincoln, NE, 
USA) after washing 3 times with phosphate-buffered saline containing 0.1% Tween-20. Membranes were first 
incubated with either anti-CB2 (1:500 NIDA-5633 Ab) or anti-calnexin (1:1,000) antibody overnight at 4 °C. After 
washing 3 times, the membranes were incubated with goat anti-rabbit IgG (IRDye 680CW) (1:2,500) for 1.5 h at 
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room temperature. Then the membranes were washed 3 times and then scanned in a Licor Odyssey Sa Imaging 
System (LI-COR Biosciences).
Immunohistochemistry. Sections were first blocked in 5% bovine serum albumin (BSA) and 0.5% Triton 
X-100 in phosphate buffer (PB) for 2 h at room temperature. Then, sections were incubated with 1:500 NIDA-
5633 mCB2R antibody (Genemed Synthesis Inc, San Antonio, TX, USA) at 4 °C overnight. After washing 3 times 
with 0.1 M PB, sections were incubated with Alexa Fluor 488 goat anti-rabbit secondary antibody (Invitrogen, 
Carlsbad, CA, USA) in 5% BSA and 0.5% Triton X-100 PB for 2 h at room temperature. Sections were then 
washed, mounted, and cover slipped. Images were taken with a fluorescence microscope (Nikon Eclipse 80i) 
equipped with a digital camera (Nikon Instruments Inc., Melville, NY, USA).
Confocal Ca2+ Imaging. Dissociated pancreatic acinar cells were first incubated with fluo-4-AM (15 μ M) 
(Molecular Probes, Eugene, OR, USA) for 15 min, followed by a 10-min rest allowing for de-esterification of 
the indicator. Confocal imaging was performed using an Olympus FluoView FV1000 microscope (Olympus 
Corporation, Center Valley, PA, USA) equipped with an argon laser (488 nm) and a UPLSAPO 40× , 0.95 NA 
objective. X-Y imaging was performed at a rate of 1.644 s per frame, 400 frames total, with a resolution of 512 × 512. 
Fluorescent fluo-4 signal was measured using ImageJ v.1.47 (available from the U.S. National Institutes of Health, 
Bethesda, MD, USA; http://imagej.nih.gov/ij/).
Solution and Chemicals. Standard extracellular solution contained (in mM): 140 NaCl, 1.0 CaCl2, 4.7 KCl, 
1.13 MgCl2, 10 glucose, and 10 HEPES, adjusted to pH 7.2 with NaOH. Pipette solution contained (in mM) 
140 KCl, 1.13 MgCl2, 5 Na2ATP, 0.24 EGTA, 10 glucose and 10 HEPES, pH 7.2. Drugs used in this study were 
GW405833 (Supplemental Fig. 1), JWH133, ACEA, and AM630, cholecystokinin (CCK), which were purchased 
from Tocris Bioscience (Minneapolis, MN, USA). Acetylcholine (ACh), amphotericin B, and L-arginine were 
purchased from Sigma-Aldrich (St. Louis, MO, USA).
CB2R antibodies, NIDA-5633 mCB2-Ab (customer-designed, raised in rabbit) that recognize the C-terminal 
(326-340 aa) of mCB2Rs, were produced by Genemed Synthesis Inc. (San Antonio, TX, USA).
Statistics. For patch-clamp experiments, the Ca2+-activated Cl− current responses were presented as the 
current charge (current area/Cm/min), and then the drug-induced changes were compared to the baseline level 
of charge (induced by ACh). When data were obtained from the same recorded cell and the changes of ACh 
response were compared before, during, and after testing drug exposure, a paired Student t test was used. To 
compare the effect of the tested drug between 2 groups of animals (e.g., saline group and L-arginine group), 
the unpaired Student t test was used. To analyze multiple effects, one-way analysis of variance (ANOVA) with 
Tukey’s post hoc tests were used.
Results
CB2Rs Are Expressed on Mouse Pancreatic Acinar Cells. Under the acutely dissociated acinar cell 
protocol, the isolated cells exhibited a typical kidney shape with secretion granules in the central area of the cells 
(Supplemental Fig. 2), suggesting the purity of the acinar cells as previously reported13,15,17. Figure 1A shows the 
results of the immunoblot assays, illustrating that a CB2-positive band was detected (at ~40 kD) in both the spleen 
and striatal tissues of WT and CB1-KO (CB1−/−), while the densities of this band in CB2-KO mice (CB2−/−) were 
substantially reduced in CB2-rich spleen tissues and almost undetectable in striatal tissues. Figure 1B shows CB2R 
immunostaining with the CB2R antibody (NIDA-5633), illustrating that the high densities of CB2R immunostain-
ing were detected in the majority of spleen cells of WT mice. In contrast, a very low density of CB2-like staining 
was detected in a minority of spleen cells in CB2R KO mice, suggesting that the NIDA-5633 antibody used is 
highly mouse CB2R-specific. We then used this antibody to detect CB2R expression in single isolated acinar cells. 
Figure 1C demonstrates the photographs taken in bright field (Ca), mouse CB2R antibody (mCB2-ir, Cb), DAPI 
(Cc), and merged mCB2-ir and DAPI (Cd). We found high densities of CB2R immunolabeling in pancreatic 
acinar cells (Fig. 1Cb,d). These results suggest that CB2R protein is expressed in dissociated mouse pancreatic 
acinar cells.
Effects of GW405833 on ACh-Induced Ca2+ Oscillations. In acutely dissociated pancreatic acinar cells, 
low nanomolar concentrations of ACh induced intracellular Ca2+ signal oscillations, which can be detected using 
patch-clamp recording and Ca2+ imaging as previously reported13,14,18–20. Our initial series of experiments was 
designed to test the effects of the CB2R agonist, GW405833 (GW), on ACh-induced Ca2+ oscillations. Figure 2A 
demonstrates an experimental protocol, in which the ACh (e.g., 10 nM) is continuously perfused to the recorded 
cell through a bath (U-tube) to get Ca2+ oscillation response (as a baseline). Then, the GW is added to the bath 
perfusion in the presence of ACh. Finally, the GW is washed out with the same concentration of ACh. With this 
protocol, the ACh is continuously perfused throughout the recording period, and we can compare the change 
of ACh-induced Ca2+ oscillations before GW perfusion (baseline), during GW perfusion, and after GW wash-
out in the same recorded cell. For statistical analysis of the effects of GW on ACh-induced Ca2+ oscillations, 
we measured baseline oscillations as the charge (current area/Cm/min)18 and compared the changes of Ca2+ 
oscillations during GW perfusion and after washout of GW to the baseline. Our data showed that in the contin-
uous presence of 10 nM ACh, 10 μ M GW reduced Ca2+ oscillations, and this inhibitory effect was reversed after 
washout (Fig. 2B). A similar inhibitory effect by GW (100 μ M) was also observed on 100 nM ACh-induced Ca2+ 
oscillations using confocal Ca2+ imaging (Fig. 2C). Statistical analysis of the Ca2+ oscillation signal from 8 cells 
tested showed that GW significantly reduced ACh-induced Ca2+ oscillations from baseline level of − 4.69 ± 0.32 
to − 1.68 ± 0.32 nC/min (the level after GW exposure, n = 8, paired t test p < 0.001, Fig. 2D). Ca2+ imaging exper-
iments also showed a similar inhibition of Ca2+ oscillations by GW (n = 66, paired t test p < 0.001, Fig. 2E). After 
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washout of GW, Ca2+ oscillations were partially recovered in both patch recording and Ca2+ imaging. These 
results suggest that activation of CB2R by GW inhibits ACh-induced intracellular Ca2+ signals in freshly isolated 
pancreatic acinar cells.
GW Inhibits ACh-Induced Ca2+Oscillations in a Concentration-Dependent Manner. To profile 
the pharmacological effect of GW on ACh-induced Ca2+ oscillations, we examined the effects of different con-
centrations of GW on 10 nM ACh-induced Ca2+ oscillations. Figure 3A–C show that GW inhibited Ca2+ oscil-
lations in a concentration-dependent manner. In 1 μ m GW group, Ca2+ oscillation levels were slightly reduced 
from baseline − 4.59 ± 1.11 to − 4.46 ± 1.25 nC/min (p > 0.05, n = 8). In 10 μ m GW group, Ca2+ oscillation levels 
were reduced from baseline − 4.69 ± 0.32 to − 1.68 ± 0.32 nC/min (p < 0.0001, n = 8). In 100 μ m GW group, Ca2+ 
oscillation levels were reduced from baseline − 5.77 ± 1.75 to − 0.50 ± 0.15 nC/min (p < 0.05, n = 5). Further com-
parisons determined that Ca2+ oscillation levels differed significantly between the following groups: GW 1 μ M vs. 
10 μ M (p < 0.05), GW 1 μ M vs. 100 μ M (p < 0.05), and GW 10 μ M vs. 100 μ M (p < 0.01), which confirms that GW 
inhibition occurs in a concentration-dependent manner.
GW Inhibits ACh-Induced Ca2+ Oscillations by a Selective Action on CB2Rs. To address the ques-
tion of whether GW inhibition of ACh-induced Ca2+ oscillations is mediated through CB2Rs, we designed 
three sets of experiments. 1) We tested the effect of a selective CB2R antagonist (AM630) on GW inhibition of 
Ca2+ oscillations. 2) We examined GW inhibitory effects on pancreatic acinar cells prepared from CB1-KO and 
CB2-KO mice. 3) We evaluated the effects of a selective CB1R agonist (ACEA) on ACh-induced Ca2+ oscillations. 
The results of these experiments demonstrated that GW inhibition of ACh-induced Ca2+ oscillations was pre-
sented in WT (Fig. 4A) and CB1R-KO mice (Fig. 4B), but was absent in CB2R-KO mice (Fig. 4C). Figure 4D sum-
marizes pooled data demonstrating the effect of GW on 30 nM ACh-induced Ca2+ oscillations in WT (p < 0.01, 
n = 5), CB1R-KO (p < 0.001, n = 6), and CB2R-KO (p > 0.05, n = 8) mice. Furthermore, co-application of AM630 
(0.1 μ M) and GW (10 μ M) abolished the inhibitory effect of GW on 10 nM ACh-induced Ca2+ oscillations (base-
line vs. AM630 + GW p > 0.05, n = 10), while AM630 alone had no affect (baseline vs. AM630, p > 0.05, n = 10, 
Fig. 4E). Finally, we found that CB1R agonist, ACEA (10 μ M) also reduced ACh-induced Ca2+ oscillations but this 
effect was likely mediated through ethanol that was used to dissolve ACEA (Supplemental Fig. 3). Together, these 
results suggest that GW inhibits ACh-induced intracellular Ca2+ signaling through the action of CB2Rs.
GW Inhibits ACh-Induced Ca2+ Oscillations through Membrane CB2Rs. Our data clearly demon-
strated that GW inhibited ACh-induced intracellular Ca2+ oscillations. However, it remained unclear whether 
Figure 1. Identification of CB2R expression in mouse pancreatic acinar cells. (A) Western blot assay shows 
that a high-density CB2-immunoreactive band is detected in both spleen and striatal tissues in WT and CB1-KO 
mice, but is undetectable in striatal tissues or substantially reduced in CB2-rich spleen tissues in CB2-KO mice. 
(B) Immunohistochemical assays show high densities of CB2-immunostaining in spleen slices of WT mice, 
which are undetectable or substantially diminished in CB2-KO mice. (C) Immunocytochemical assays use 
mouse CB2R antibody (NIDA-5633). The bright field photograph (Ca) shows freshly dissociated pancreatic 
acinar cells. CB2-immunostaining (mCB2-ir) in single dissociated pancreatic acinar cells illustrates the high 
densities of CB2R proteins (Cb). DAPI staining demonstrates cell nucleus (Cc). The “Merged” image shows 
superimposed mCB2-ir and DAPI images (Cd).
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GW inhibition was mediated through extracellular or intracellular CB2Rs. GW could act on extracellular mem-
brane CB2Rs and/or modulate muscarinic receptors, or GW could affect intracellular CB2Rs, and then mod-
ulate signal molecules such as G-protein and/or inositol 1,4,5-trisphosphate (IP3) receptors21. To distinguish 
among these possibilities, we designed two experiments, in which, either the CB2R agonist (GW) or antagonist 
(AM630) was applied internally or in which, IP3 was applied internally. When GW (100 μ M) was added into the 
recording electrode and a perforated whole-cell recording (amphotericin B) was performed, bath-application of 
10 nM ACh induced Ca2+ oscillations. When the recording mode was switched from perforated to conventional 
Figure 2. Effects of the CB2R agonist on ACh-induced Ca2+ oscillations in dissociated pancreatic acinar 
cells. (A) Experimental protocol shows continuous exposure to ACh (baseline), addition of GW on top of ACh, 
and washout of GW (with ACh). A typical trace of ACh-induced Ca2+ oscillations measured using patch-clamp 
whole-cell recording in voltage-clamp mode (measuring Ca2+-dependent Cl− current). In the continuous 
presence of ACh (10 nM), addition of GW (10 μ M) reversibly reduced Ca2+ oscillations. (B) A typical trace 
of ACh-induced Ca2+ oscillations measured using confocal Ca2+ imaging; GW (100 μ M) inhibited ACh 
(100 nM)-induced Ca2+ oscillations. Statistical analysis shows that GW significantly reduces ACh-induced Ca2+ 
oscillations in both patch-clamp recording (C) and Ca2+ imaging experiments (D). (D) The net charge of ACh-
induced baseline Ca2+ oscillations (prior to GW application) is compared to the charge during GW application 
(+ GW) and during washout of GW (Washout). Numbers in parentheses indicate the number of cells tested. 
Columns indicate the mean of current charge ± SEM (left) and the mean DF/DO ± SEM (right) as compared to 
the baseline level. * * * Indicates p < 0.001 for the value compared to baseline level. Statistic comparison between 
the levels of baseline and washout of GW showed significance (p < 0.05) in patch-clamp data (Fig. 2D left panel) 
and in Ca2+ imaging data (p < 0.01, Fig. 2D right panel).
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whole-cell recording by a brief suction, GW was infused into the recorded cell, and no detectable inhibitory effect 
on ACh-induced Ca2+ oscillations was present (Fig. 5A,D). Using the same experimental protocol, we applied 
AM630 (1 μ M) intracellularly and found that internal AM630 failed to prevent bath-applied GW-induced inhi-
bition in the ACh-induced Ca2+ oscillations (Fig. 5B,D). In the presence of intracellularly applied IP3 (30 μ M), 
which causes IP3-induced Ca2+ oscillations, GW produced little inhibitory effect on the IP3-induced Ca2+ oscil-
lations (Fig. 5C,D). These data suggest that GW inhibition of ACh-induced Ca2+ oscillations is not mediated 
through intracellular IP3 receptors. Together, these results suggest that GW inhibition of intracellular Ca2+ oscil-
lations is mediated through CB2Rs on the surface of the cytoplasmic membrane.
Effects of GW on CCK-Induced Ca2+ Oscillations. Data presented thus far demonstrate that GW inhib-
ited ACh-induced Ca2+ oscillations through cell membrane CB2Rs, perhaps through CB2Rs and muscarinic 
receptor cross talk. To test this possibility, we applied CCK to induce Ca2+ oscillations, which occurs through dif-
ferent receptor signaling pathway than muscarinic receptor, and examined the effects of GW on the CCK-induced 
Figure 3. GW inhibits ACh (10 nM)-induced Ca2+ oscillations in a concentration-dependent manner. 
Typical traces show the effect of different concentrations of GW: (A) 1 μ M, (B) 10 μ M, (C) 100 μ M. (D) Bar 
graph summarizes the concentration-dependent effect of GW on ACh-induced Ca2+ oscillations. The number 
of cells tested is stated for each condition in parentheses. Columns show the mean of charge ± SEM. * Indicates 
p < 0.05, * * * Indicates p < 0.001 for the values between baseline level of ACh response indicated as open 
columns at left and the level after GW exposure (solid columns). No asterisk mark means (GW 1 μ M group) 
p > 0.05.
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Ca2+ oscillations. As shown in Fig. 6, bath application of 10 pM CCK induced Ca2+ oscillation responses, which 
were not affected by bath application of GW (100 μ M, Fig. 6A). In the same recorded cell, bath application of GW 
(100 μ M) dramatically inhibited 10 nM ACh-induced Ca2+ oscillations (Fig. 6B). Figure 6C summarizes pooled 
data from 4 cells tested, and no significant effect of GW on CCK-induced Ca2+ oscillations was found (p > 0.05, 
n = 4, Ca), but GW inhibited ACh-induced Ca2+ oscillations in the same recorded cell (p < 0.01, n = 4, Cb).
L-arginine Potentiates ACh-Induced Ca2+ Oscillations. L-arginine is used to induce acute pancre-
atitis in rodents22. In dissociated pancreatic acinar cells, bath-application of L-arginine for 10 min enhanced 
ACh-induced Ca2+ oscillations from baseline level of 4.93 ± 0.39 to 10.34 ± 1.83 nC/min (Fig. 7Aa,b), which 
was not reversible after washout for 10 min (Ca2+ oscillations between L-arginine exposure and washout groups 
p > 0.05, n = 6, Fig. 7Ac). Statistical analysis revealed that L-arginine significantly enhanced ACh-induced Ca2+ 
oscillations (p < 0.05) in an irreversible manner (Fig. 7B).
Figure 4. GW (10 μM) inhibits ACh-induced Ca2+ oscillations through CB2Rs. (A) A typical trace shows the 
effect of GW on ACh (30 nM)-induced Ca2+ oscillations in WT mice cells. (B) GW fails to inhibit ACh-induced 
Ca2+ oscillations in acinar cells prepared from CB1R-KO mice. (C) GW inhibits ACh-induced Ca2+ oscillations 
in acinar cells prepared from CB2R-KO mice. (D) Columns show the mean of charge ± SEM, summarizing the 
effect of GW on ACh-induced Ca2+ oscillations in WT, CB1R-KO and CB2R-KO mice cells. The number of cells 
tested is stated for each condition in parentheses. * * Indicates p < 0.01 compared to the baseline level of ACh 
response (open columns) to the level after GW exposure (solid columns). (E) Bar graph demonstrates that the 
CB2R antagonist (AM630) alone does not significantly affect ACh-induced Ca2+ oscillation response (baseline 
vs. AM630: p > 0.05) but abolishes GW-induced inhibition (baseline vs. Am630 + GW: p > 0.05).
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GW Prevents L-arginine-Enhanced Ca2+ Oscillations. Next, we sought to determine whether GW 
could eliminate L-arginine-induced enhancement of Ca2+ oscillations. We showed that either pre-treatment 
with GW (Fig. 8A), or co-administration of GW (10 μ M) and L-arginine (Fig. 8B), abolished L-arginine-induced 
enhancement of Ca2+ oscillations (Fig. 8C,D), suggesting that selective activation of acinar cell CB2Rs signifi-
cantly eliminates L-arginine-induced enhancement of intracellular Ca2+ signals in mouse pancreatic acinar cells.
GW Improves L-arginine-Induced Pathology. Finally, we tested whether systemic injection of GW 
can prevent L-arginine-induced elevation of Ca2+ oscillations, and subsequent pathological changes including 
enhancement of pancreatic amylases (AMS) and pulmonary peritoneal macrophages (MPO) levels, which are 
two major effects present in early-stage of acute pancreatitis. We injected L-arginine (4.0 g/kg, i.p.) to establish an 
acute pancreatitis model23,24, and dissociated pancreatic acinar cells 24 hours later, then compared ACh-induced 
Ca2+ oscillations between saline- and L-arginine-treated groups using Ca2+ imaging. Systemic L-arginine injec-
tion enhanced ACh-induced Ca2+ oscillations compared to systemic saline injection, but GW and L-arginine 
co-injected showed similar level of ACh-induced Ca2+ oscillations (Fig. 9A). Compared to the ACh-induced 
Ca2+ oscillations in saline-treated mice, the acinar cells prepared from L-arginine–treated mice showed a signif-
icant increase in Ca2+ oscillation response (saline vs. L-arginine group, p < 0.01), while co-injection of GW and 
L-arginine reduced L-arginine’s effect (saline vs. L-arginine + GW group, p > 0.05). These results suggest that 
the activation of pancreatic acinar cell CB2Rs may prevent early pathogenesis of acute pancreatitis through the 
inhibition of enhanced intracellular Ca2+ signals. In addition, co-injection of GW (10 mg/kg, i.p.) and L-arginine 
(4 g/kg, i.p.) also significantly reduced pancreatic L-arginine-induced enhancement of AMS (saline vs. L-arginine, 
p < 0.05, and saline vs. GW + L-arginine, p > 0.05; Fig. 9C) and pulmonary MPO levels (saline vs. L-arginine, 
p < 0.05, and saline vs. GW + L-arginine, p > 0.05; Fig. 9D). These results suggest that the activation of pancreatic 
acinar cell CB2Rs may prevent early pathogenesis of acute pancreatitis through the inhibition of intracellular Ca2+ 
signals.
Discussion
The novel findings of this study are that the activation of membrane CB2Rs by GW reduces ACh-, but 
not CCK-induced intracellular Ca2+ oscillations, and GW induced reduction of Ca2+ oscillations in a 
Figure 5. GW inhibits ACh-induced Ca2+ oscillations through cytoplasmic, rather than intracellular, 
CB2Rs. (A) A typical trace shows ACh-induced Ca2+ oscillations between perforated and conventional whole-
cell recordings, in which the pipette solution contained 100 μ M GW. Infusion of GW into the recorded cell does 
not reduce ACh-induced Ca2+ oscillations (Aa). Ab: Summary of pooled data, demonstrating no significant 
difference between ACh responses with and without intracellular GW (p > 0.05, n = 6). (B) Internal infusion of 
AM630 fails to prevent bath-applied GW inhibition of ACh-induced Ca2+ oscillations. * * Indicates p < 0.01.  
(C) Intracellular applied IP3-induced Ca2+ oscillations are not sensitive to bath-applied GW (Ca). (Cb) Bar 
graph summarizes the effect of GW on IP3-induced Ca2+ oscillations and showing no significance before and 
after GW exposure (p > 0.05, n = 7). The number of cells tested is stated for each condition in parentheses.
www.nature.com/scientificreports/
9Scientific RepoRts | 6:29757 | DOI: 10.1038/srep29757
concentration-dependent manner. The CB2R-mediated reduction of ACh-induced Ca2+ oscillations is abolished 
by pharmacological blockade of CB2Rs (AM630) or is absent in CB2-KO mice, but not in CB1-KO mice. The pan-
creatitis inducer, L-arginine, significantly enhances ACh-induced intracellular Ca2+ oscillations, and the CB2R 
agonist, GW, abolishes this L-arginine effect. In addition, this CB2R agonist also improved L-arginine-induced 
pathological changes. Collectively, our data demonstrate that CB2R agonist GW reduces ACh-enhanced intracel-
lular Ca2+ signals in mouse pancreatic acinar cells, and this may underlie an important cellular mechanism for a 
CB2R agonist to serve as a new candidate for treating acute pancreatitis.
CB2R Expression in Mouse Pancreatic Acinar Cells. Previously, in rodent pancreatic acinar cells, CB2R 
protein expression was found using immunohistochemical staining and Western blot10,25. In mouse pancreatic tis-
sue, both CB1R and CB2R mRNA were identified using real-time RT-PCR and immunohistochemical staining10. 
In the present study, we confirmed that CB2R proteins were expressed in freshly isolated mouse pancreatic acinar 
cells, which is consistent with previous report10. Our data demonstrate that CB2Rs are expressed in mouse pan-
creatic acinar cells and they may play an important role in modulating acinar cells function.
CB2R Agonist Reduces ACh-Induced Ca2+ Oscillations in Mouse Pancreatic Acinar Cells. Mouse 
pancreatic acinar cells have been used as an excellent cell model of agonist-induced Ca2+ oscillations for studying 
pancreatitis26. We examined whether a selective CB2R agonist, GW, affected ACh-induced Ca2+ oscillations in 
the isolated pancreatic acinar cells through CB2Rs. Using both patch-clamp recording and confocal Ca2+ imag-
ing techniques, we found that GW significantly reduced ACh-induced Ca2+ oscillations, and this inhibition is 
GW-concentration dependent. We also tested another selective CB2R agonist, JWH-133, on the ACh-induced 
Figure 6. Effects of GW on CCK-induced Ca2+ oscillation. (A) Representative typical trace of CCK (10 pM)-
induced Ca2+ oscillations, which are not affected by 100 μ M GW. (B) In the same recorded cell, ACh (10 nM)-
induced Ca2+ oscillations are completed eliminated by GW. (C) Bar graph summarizes the effect of 100 μ M GW 
on CCK (Ca)- and ACh (Cb)-induced Ca2+ oscillations. No asterisk mark (CCK vs CCK + GW 100 μ M) means 
p > 0.05 (n = 4). * * Indicates p < 0.01 compared between ACh 10 nM and ACh + GW 100 μ M, n = 4.
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Ca2+ oscillations, and found a similar inhibition (Supplemental Fig. 4), but the inhibitory effect of JWH-133 was 
weaker (a higher concentration of JWH-133 was needed compared with GW to induce the same inhibition). It 
was reported that GW acts as a potent and selective partial agonist for CB2R with an EC50 of 0.65 nM and selec-
tivity of around 1200× for CB2R over CB1R27,28, while JWH-133 has an EC50 of 3.4 nM and selectivity of around 
200× for CB2R over CB1R29. These findings may explain why GW is more potent than JWH-133 for ACh-induced 
Ca2+ oscillations.
Accumulating evidence demonstrates a complex relationship between the cannabinoid ligand (and recep-
tors) and intracellular Ca2+ signals in different types of cells. For example, on one hand, activation of cannab-
inoid CB1R or CB2R increased (initiated) intracellular Ca2+ levels in endothelia cells30, submandibular acinar 
cells31, canine kidney cells32, and bladder cancer cells33. On the other hand, in pancreatic beta cells, the activation 
of either CB1R34 or CB2R35 reduced glucose-induced intracellular Ca2+ oscillations and insulin release. It has 
been reported that anandamide reduced intracellular Ca2+ concentration through the suppression of a Na+/Ca2+ 
exchanger current in rat cardiac myocytes36. To our knowledge, ours is the first report that a selective CB2R ago-
nist reduces intracellular Ca2+ signals in mouse pancreatic acinar cells. Considering that Ca2+ plays an important 
role in cellular function, especially enzyme secretion in pancreatic acinar cells, our data suggest that CB2R mod-
ulates an important aspect of pancreatic acinar cell physiology and pathophysiology.
CB2R Agonist Reduces ACh-Induced Ca2+ Oscillations through Membrane CB2Rs. Cannabinoid 
ligands exert their pharmacological effects through CB1R or CB2R, but in some cases they also can act on 
non-cannabinoid targets37. We determined whether GW modulated intracellular Ca2+ signals through a cell 
membrane or cytosolic CB2Rs. First, we examined the effects of pharmacological manipulations of CB1R and 
Figure 7. Effects of L-arginine on ACh-induced Ca2+ oscillations. (A) Representative traces of ACh-induced 
Ca2+ oscillations before (A), during (B), and after (C) bath-application of L-arginine (10 mM, L-Arg). Traces 
(A–C) were recorded from the same cell. (B) Bar graph summarizes the charge (± SEM) and shows an enhanced 
effect of L-Arg on ACh-induced Ca2+ oscillations. Six cells were assessed before and after L-Arg application.  
* Indicates p < 0.05 compared to baseline level. There was no significance between L-Arg application and 
washout of L-Arg (p > 0.05), suggesting the effects of L-Arg is non-reversible.
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CB2R and found that the CB2R selective antagonist AM630 abolished GW-induced reduction of Ca2+ oscillations, 
suggesting that GW modulates ACh-induced Ca2+ oscillations through the CB2Rs. Then, we genetically manip-
ulated cannabinoid receptors and compared the effects of GW on Ca2+ oscillations between WT and CB2R-KO 
mice, and also WT and CB1R-KO mice. We found that in CB2R-KO but not CB1R-KO mice, GW lost its inhibitory 
effect, further confirming that CB2R is the key target for mediating GW-induced reduction in Ca2+ oscillations.
In a group of cells tested, we found that a CB1R agonist, ACEA (dissolved by ethanol; 10-μ M ACEA solution 
contained 7.3-mM ethanol) reduced ACh-induced Ca2+ oscillations (Supplemental Fig. 3); however, the control 
experiments using the same concentration of ethanol (7.3 mM) also reduced ACh-induced Ca2+ oscillations, and 
the inhibitory effect of ACEA was not absent in the acinar cells dissociated from CB1R-KO mice, suggesting a 
non-specific effect, likely caused by ethanol. In addition, we also tested the effects of DMSO (GW was dissolved by 
DMSO to 100 mM stock solution), and found that 1 μ M DMSO itself did not affect ACh-induced Ca2+ oscillations 
(Supplemental Fig. 5). Together, our data support the conclusion that GW selectively acts on acinar cell CB2Rs 
and reduces ACh-induced Ca2+ oscillations.
Figure 8. Effects of GW on L-Arg induced enhancement of Ca2+ oscillations. (A) After pretreatment with 
GW, bath-applied L-Arg (10 mM for 10 min) fails to enhance ACh-induced Ca2+ oscillations. Traces in  
Fig. 8Aa,b were recorded from the same cell. (B) Without pretreatment, bath-applied L-Arg enhances 
ACh-induced Ca2+ oscillations, and under this condition, the addition of GW also reduces L-Arg-induced 
enhancement of Ca2+ oscillations. Traces in Fig. 8Ba,b were recorded from the same cell. (C,D) GW 
significantly blocks L-Arg-induced enhancement of Ca2+ oscillations either with or without pretreatment of 
GW. Bar graphs represent averaged charge  ± SEM. The number of cells tested is stated for each condition in 
parentheses. * Indicates p < 0.05, * * * Indicates p < 0.001.
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Finally, we asked where the CB2Rs are located (membrane or cytosolic CB2Rs). To address this question, we 
designed three experiments. We first examined the effect of bath-applied GW on the Ca2+ oscillations induced 
by intracellular application of IP3, and found that GW did not affect IP3-induced Ca2+ oscillations, suggest-
ing that the target that mediated GW-induced inhibition in Ca2+ oscillations is located in the signal pathway 
before IP3 receptors, and not on the IP3 receptor itself. We then intracellularly applied GW through a record-
ing electrode to examine the effect of intracellular administration of GW on bath ACh-induced Ca2+ oscilla-
tions, and found that intracellular infusion of GW (even at 100 μ M) did not alter ACh-induced Ca2+ oscillations. 
Finally, we intracellularly applied AM630 through a recording electrode to examine the effect of bath-applied 
GW on ACh-induced Ca2+ oscillations. Our data showed that intracellular infusion of AM630 did not prevent 
bath-applied GW-induced reduction of Ca2+ oscillations. Collectively, our data support the conclusion that GW 
modulates intracellular Ca2+ signaling through the membrane CB2Rs in pancreatic acinar cells.
Possible Mechanisms of GW-Induced Reduction in ACh-Induced Ca2+ Oscillations. The pre-
cise mechanism by which GW modulates intracellular Ca2+ signals is unclear. Our data show that membrane 
CB2Rs are necessary for mediating GW’s effect. GW’s action in ACh-induced Ca2+ oscillations should occur at 
the G-protein-mediated signal pathway between muscarinic receptor (M3) activation and IP3 production because 
GW did not affect IP3-induced Ca2+ oscillations. We also demonstrated that GW failed to affect ACh-induced 
Ca2+ oscillations in pancreatic acinar cells prepared from CB2R-KO mice, suggesting that GW likely did not affect 
muscarinic receptor function. In addition, we found that bath-applied GW failed to inhibit CCK-induced Ca2+ 
oscillations even at 100 μ M, suggesting that GW selectively modulates muscarinic receptor-mediated G-protein 
signaling38. Therefore, the possible mechanisms for GW-induced modulation of ACh-induced Ca2+ oscillations 
may involve cross talk between muscarinic receptor- and CB2R-mediated G-protein signal pathways, such as 
homologous and/or heterologous desensitization of G-protein coupled receptors (GPCRs)39. For example, in 
the case of homologous desensitization of GPCRs, the activation of one type of GPCR can rapidly terminate 
another GPCR signaling through the internalization of receptors after binding, phosphorylation of G-protein 
coupled receptor kinases, and formation of complexes with β -arresting39,40. In addition, the activation of a GPCR 
may also result in temporary inhibition of another GPCR signal through a heterologous desensitization, which 
Figure 9. Effects of GW on L-Arg-induced pathology. (A) Representative comparison of ACh-induced Ca2+ 
oscillations between the acinar cells prepared from L-Arg (4 g/kg, i.p.) and normal saline (NS) treated mice 
(after injection for 24 h). These demonstrate an enhancement of ACh-induced Ca2+ oscillations in L-Arg-
treated mice compared to NS-treated mice. This enhanced effect is prevented by co-injection of GW and L-Arg 
(GW + L-Arg). (B) In these studies, we measured Ca2+ responses as ∆ F/F0, where F refers to the current Fluo 
signal intensity, F0 refers to the background Fluo signal intensity, and ∆ F/F0 refers to the change of F/F0. Using 
the same measurement, we compared ACh-induced Ca2+ responses from pancreatic acinar cells collected from 
three groups of mice: control (saline-treated mice), L-Arg, and L-Arg plus GW. Compared to the ACh-induced 
Ca2+ oscillations in saline group, there is a significant enhancement of ACh-induced Ca2+ oscillations in L-Arg 
group (* * Indicates p < 0.01), and there is no statistically significant difference between saline and GW + L-Arg 
groups (#indicates p > 0.05), suggesting a prevention of L-Arg-induced enhanced effect by GW. In addition, GW 
also prevents L-Arg-induced elevation of pancreatic AMS (C) and pulmonary MPO (D). The number of cells 
tested is stated for each condition. Bars represent mean ± SEM. In parts C and D, * Indicates p < 0.05 between 
saline and L-Arg groups, but there is no statistically significant difference between saline and L-Arg + GW 
group (#indicates p > 0.05).
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does not involve receptor internalization, but activation of several signal transduction pathways, particularly 
protein kinase C (PKC)- and PKA-dependent signaling pathways38,41. It has been reported that intracellular cyclic 
AMP-generated substances play an important role in regulation of IP3 and Ca2+ responses to ACh in rat subman-
dibular acini. Investigators found that intracellular cAMP increased IP3 formation in response to ACh, while 
blocking PKA by H89 reduced IP3 formation41. Because it is well known that the activation of CB2Rs significantly 
reduces intracellular cAMP levels, we thus postulated that GW may activate CB2Rs, reduce cAMP, and in turn 
reduce intracellular IP3 production, and lead to a reduction of ACh-induced Ca2+ oscillations. Our findings war-
rant further testing of this hypothesis.
Clinical Significance of CB2R-Mediated Reduction of Ca2+ Oscillations in Pancreatic Acinar 
Cells. Pancreatic acinar cells are functional units of the exocrine pancreas. They synthesize, store, and secrete 
inactive preforms of digestive enzymes into the lumen of the acinus. The activity of pancreatic acinar cells is 
crucially modulated by the secretagogues ACh and CCK; both can act on their specific membrane receptors 
(muscarinic and CCK receptor, respectively) and then induce an elevation in cytoplasmic calcium. If high con-
centrations of intracellular Ca2+ persist, intracellular signaling is disrupted, cell damage occurs, and acute pan-
creatitis forms. Emerging evidence suggests that the earliest abnormalities of acute pancreatitis arise by aberrant 
elevation of intracellular Ca2+ within acinar cells because the sustained intracellular Ca2+ elevation activates 
intracellular digestive proenzymes resulting in necrosis and inflammation, and pharmacological blockade of 
store-operated or Ca2+ release-activated Ca2+ channels would prevent sustained elevation of intracellular Ca2+, 
and consequence protease activation and necrosis3. In the present study, we provide the first evidence that the 
CB2R agonist, GW, reduces ACh-induced Ca2+ oscillations, abolishes L-arginine–induced enhancement of Ca2+ 
oscillations and prevents L-arginine–induced elevation of both pancreatic AMS and pulmonary MPO levels. 
These results suggest that a CB2R agonist may serve as a novel therapeutic strategy to prevent and/or treat acute 
pancreatitis. This conclusion is consistent with previous report that a CB2R agonist exhibits a protective effect 
on pathogenesis in an acute pancreatitis animal model10. Our data showing a reduction of intracellular Ca2+ 
signaling by GW also provide a new target to interpret the role of CB2R agonists in treating acute pancreatitis in 
addition to CB2R-mediated anti-inflammation.
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